[Is Chronic Obstructive Pulmonary Disease a Protective Factor in SARS-CoV-2 Infection? The Importance of Bronchodilator Treatment]

Overview

Journal Rev Clin Esp

Specialty General Medicine

Date 2024 Apr 15

PMID 38620449

Authors

R Boixeda

L Campins

J Juanola

L Force

Affiliations

Soon will be listed here.

Citing Articles

[Corticoid treatment and SARS-CoV-2 variants: two independent factors associated with COVID-19 mortality in a Spanish regional hospital].

Salas Jarque J, Moreno Diaz J, Bustos Morell C, Pereira Boan J, Duran Portella A, Ruiz Montes F An Sist Sanit Navar. 2023; 46(1).

PMID: 37203319 PMC: 10205026. DOI: 10.23938/ASSN.1017.

[Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave].

Gomez-Antunez M, Muino-Miguez A, Bacete-Cebrian M, Rubio-Rivas M, Lebron Ramos J, de Cossio Tejido S Rev Clin Esp. 2023; 223(5):298-309.

PMID: 37124999 PMC: 10040358. DOI: 10.1016/j.rce.2023.02.003.

Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave.

Gomez-Antunez M, Muino-Miguez A, Bacete-Cebrian M, Rubio-Rivas M, Lebron Ramos J, de Cossio Tejido S Rev Clin Esp (Barc). 2023; 223(5):298-309.

PMID: 37028707 PMC: 10074726. DOI: 10.1016/j.rceng.2023.04.002.

[Potentially useful drugs in the treatment of COVID-19 in Primary Care].

Garcia-Matarin L, Velilla-Zancada S, Trillo-Calvo E, Molina-Escribano F, Serrano-Cumplido A Semergen. 2021; 48(2):137-148.

PMID: 34454827 PMC: 8316068. DOI: 10.1016/j.semerg.2021.06.009.

Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.

Gomez Antunez M, Muino Miguez A, Bendala Estrada A, Maestro de la Calle G, Monge Monge D, Boixeda R Int J Chron Obstruct Pulmon Dis. 2021; 15:3433-3445.

PMID: 33447021 PMC: 7801905. DOI: 10.2147/COPD.S276692.

References

Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K . Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020; 58(3):155-168. PMC: 7102607. DOI: 10.1016/j.resinv.2019.12.005. View

Zwaans W, Mallia P, van Winden M, Rohde G . The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—a systematic review. J Clin Virol. 2014; 61(2):181-8. PMC: 7106508. DOI: 10.1016/j.jcv.2014.06.025. View

Bucher H, Duechs M, Tilp C, Jung B, Erb K . Tiotropium Attenuates Virus-Induced Pulmonary Inflammation in Cigarette Smoke-Exposed Mice. J Pharmacol Exp Ther. 2016; 357(3):606-18. PMC: 4885512. DOI: 10.1124/jpet.116.232009. View

Godoy P, Romero A, Soldevila N, Torner N, Jane M, Martinez A . Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16. Euro Surveill. 2018; 23(43). PMC: 6208006. DOI: 10.2807/1560-7917.ES.2018.23.43.1700732. View

Iwabuchi K, Yoshie K, Kurakami Y, Takahashi K, Kato Y, Morishima T . Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases. J Infect Chemother. 2020; 26(6):625-632. PMC: 7161498. DOI: 10.1016/j.jiac.2020.04.007. View

Chen C, Lee C, Liu C, Wang J, Wang L, Perng R . Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc. 2005; 68(1):4-10. PMC: 7129615. DOI: 10.1016/S1726-4901(09)70124-8. View

Morros R, Vedia C, Giner-Soriano M, Casellas A, Amado E, Baena J . [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT]. Aten Primaria. 2018; 51(6):333-340. PMC: 6837040. DOI: 10.1016/j.aprim.2018.02.007. View

Alraddadi B, Watson J, Almarashi A, Abedi G, Turkistani A, Sadran M . Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014. Emerg Infect Dis. 2015; 22(1):49-55. PMC: 4696714. DOI: 10.3201/eid2201.151340. View

Mehta N, Kalra A, Nowacki A, Anjewierden S, Han Z, Bhat P . Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(9):1020-1026. PMC: 7201375. DOI: 10.1001/jamacardio.2020.1855. View

10.

Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y . Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75(7):1730-1741. DOI: 10.1111/all.14238. View

11.

de Oliveira J, Aguiar I, de Oliveira Beloto A, Santos I, Leitao Filho F, Malosa Sampaio L . Clinical significance in COPD patients followed in a real practice. Multidiscip Respir Med. 2013; 8(1):43. PMC: 3706245. DOI: 10.1186/2049-6958-8-43. View

12.

Casas-Mendez F, Abadias M, Yuguero O, Bardes I, Barbe F, de Batlle J . Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality. PLoS One. 2018; 13(12):e0208847. PMC: 6294427. DOI: 10.1371/journal.pone.0208847. View

13.

Malosh R, Martin E, Callear A, Petrie J, Lauring A, Lamerato L . Respiratory syncytial virus hospitalization in middle-aged and older adults. J Clin Virol. 2017; 96:37-43. PMC: 5889293. DOI: 10.1016/j.jcv.2017.09.001. View

14.

Halpin D, Singh D, Hadfield R . Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020; 55(5). PMC: 7236828. DOI: 10.1183/13993003.01009-2020. View

15.

Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G . Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020; 382(25):2431-2440. PMC: 7206933. DOI: 10.1056/NEJMoa2006923. View